GP says she was forced out of job after raising concerns about gender treatment

Redvers raised concerns about clinical assessment, prescribing and supervision, not about patients’ identities. She questioned whether another GP was assessing vulnerable young people appropriately and whether treatment had enough medical evidence behind it.

In July 2020, a doctor contacted her about an overseas online clinic seeking testosterone prescribing for a distressed 18-year-old. Other GPs later raised concerns about puberty blockers, cross-sex hormones and limited specialist supervision at WellBN. Redvers passed concerns to NHS England and supported investigations.

She says the response shifted attention from patient safety to allegations of transphobia. An investigation described one colleague’s interest as disproportionate, which she believed referred to her. She brought a constructive-dismissal claim against NHS Sussex ICB and Adam Doyle. NHS Surrey and Sussex apologised and said some employment processes should have been handled differently.

Constructive dismissal generally means an employee resigns because the employer has seriously breached the employment relationship, rather than being directly dismissed. The employee must usually show that the employer’s conduct made continuing in the job untenable. The article does not give the tribunal’s final decision.

Redvers says she was accused of transphobia, bullied and harassed after passing on doctors’ concerns. She also says the investigation focused on her instead of medical and safeguarding issues. NHS Surrey and Sussex acknowledged that some employment processes should have been handled differently and apologised.

Her claim names NHS Sussex Integrated Care Board, which managed local health services, and Adam Doyle, its chief executive until 2025. The tribunal heard her evidence over three weeks. The claim matters because it tests whether workplace treatment effectively drove out a doctor who believed she was carrying out safeguarding duties.

A named safeguarding GP is a doctor designated to support safeguarding work in a local NHS area. The article says other doctors with safety concerns about patients could turn to Redvers for advice and help. This role places patient welfare at the centre of reporting and response.

Redvers held that role for Sussex and had many years of experience with vulnerable groups. In July 2020, a doctor contacted her about an 18-year-old who was distressed about gender and had attended an overseas online clinic. Redvers then spoke to NHS England and was advised to make a whistleblower complaint.

The role matters because it provides a route for concerns to be heard beyond an individual consultation. Other GPs later brought her concerns about assessments, prescribing and supervision at WellBN. Investigations followed, although Redvers says the focus on her ultimately sidelined patient-safety questions.

A separate NHS safety investigation found that 78 children at the WellBN practice had potentially been harmed. The children included some as young as 13. The finding made the scale of the safety concern much clearer than the earlier employment dispute.

The report said puberty-blocking drugs and cross-sex hormones had been prescribed without proper checks. NHS England said some WellBN practitioners provided care they were not commissioned to deliver. The investigation followed a drug review carried out in autumn 2024, not the concerns Redvers first raised years earlier.

The timing is central to the story. Redvers had raised concerns nearly six years before the June 2026 report, but the report did not arise from those original complaints. She said it was upsetting to read that harm might have been stopped because leaders knew concerns had been raised. NHS England called the situation totally unacceptable.

The article does not specify particular medical outcomes from the prescriptions. It does establish that 78 children had potentially been harmed and that drugs were given without proper checks. It also describes the patients as vulnerable and the care as medically complex.

The reported safety mechanism is a failure of safeguards before treatment. Concerns included the quality of assessments, prescribing of puberty blockers and cross-sex hormones, and a lack of specialist supervision at WellBN. NHS England said practitioners provided care they were not commissioned to deliver.

These gaps can make it harder to identify whether treatment is appropriate and whether patients’ needs have been properly assessed. That conclusion follows from the article’s emphasis on checks, evidence and supervision; it does not provide a detailed list of clinical outcomes. The safety investigation found potential harm, while Redvers said earlier concerns had been sidelined.

The article describes several reporting routes for NHS staff who fear patient care may be unsafe. A doctor can approach a named safeguarding GP for advice and help. Concerns can also be passed to NHS England, including through a whistleblower complaint. Formal NHS investigations may then examine the practice or clinician involved.

Redvers used this pathway after a doctor contacted her about testosterone prescribing for a vulnerable 18-year-old. She spoke to NHS England and was advised to make a complaint as a whistleblower. Later, other GPs brought her concerns about assessments, hormone prescribing and specialist supervision at WellBN.

The article also shows that reporting does not guarantee immediate action. NHS investigations initially found no cause for concern about Hall’s work, while a later safety investigation found potential harm involving 78 children. Staff can therefore raise concerns through safeguarding, whistleblowing and formal review, but the article does not set out every NHS procedure.

For vulnerable patients, complex treatment decisions should be based on careful medical assessment and evidence. Safeguarding must remain central, especially when doctors identify possible risk. The article presents these responsibilities as part of getting treatment right for a complex group of patients.

Redvers questioned treatment recommended for patients who had not been assessed or met by the recommending doctor. Other concerns involved weak specialist supervision and care that NHS England said practitioners were not commissioned to provide. These examples show why professional oversight and clear service boundaries matter.

The article also points to regulation through NHS investigations and safety reviews. Initial investigations found no cause for concern, but a later review found 78 children had potentially been harmed. The forward lesson is that concerns need to be heard, examined independently and connected to patient-safety action, rather than becoming only employment or reputational disputes.